Zhuhaishi Shuangbojie Technology Co.,Ltd.

Zhuhaishi Shuangbojie Technology Co.,Ltd.

You are here: HomeProductsDSIP (Delta sleep-inducing peptide)

Contact us

  • Company Name: Zhuhaishi Shuangbojie Technology Co.,Ltd.
  • Street: NO.101,Guofang Road,Gongbei,Zhuhai
  • City: zhuhai
  • Province/state: Guangdong
  • Country/region: China
  • Contact Person: Ms.Merry Chou
  • Department: Sales
  • Tel: 86-0756-8889897
  • Fax: 86-0756-8889806
  • Email:

DSIP (Delta sleep-inducing peptide)

  • CAS No:62568-57-4 Deltasleep-inducing peptide (rabbit)
    Molecular Structure

    Detailed Description

    DSIP (Delta sleep-inducing peptide)
    Synonyms: Sleep inducing peptide;Waggdasge;Trp-ala-gly-gly-asn-ala-ser-gly-glu;Trp-ala-gly-gly-asp-ala-ser-gly-glu;Trp-ala-gly-gly-asp-ala-ser-gly-glu 4h2o;Delta sleep inducing peptide;Delta sleep-inducing peptide 4h2o;Dsip
    CAS: 62568-57-4
    MF: C35H48N10O15
    MW: 848.81
    Product Categories: Peptide

    Delta sleep-inducing peptide alters bispectral index, the electroencephalogram and heart rate variability when used as an adjunct to isoflurane anaesthesia.
    Abstract
    BACKGROUND AND OBJECTIVE:
    Delta sleep-inducing peptide (DSIP) is an endogenous peptide that crosses the blood-brain barrier, named after its association with natural sleep and enhanced electroencephalogram (EEG) delta rhythm. The objective of this study was to determine whether DSIP could be used as an adjunct to volatile anaesthesia in humans, our hypothesis being that DSIP is a natural hypnotic that would increase anaesthetic depth. The aims were to assess depth of anaesthesia using bispectral index (BIS), the EEG and heart rate variability (HRV), and to determine whether DSIP altered the symmetry of EEG between the left and right cerebral hemispheres.
    METHODS:
    Twenty-four female ASA I or II patients gave written, informed consent to a protocol approved by our local research ethics committee. Twelve were randomly assigned as controls to receive saline. The other 12 were randomly allocated to receive one of three intravenous bolus doses of DSIP (Clinalfa) at 25, 50 or 100 nmol kg(-1). The first administration of DSIP was while awake and the second after induction of anaesthesia with propofol and maintenance with isoflurane. BIS and EEG parameters were measured continuously using a bilateral electrode montage.
    RESULTS:
    DSIP significantly increased heart rate, decreased HRV and, paradoxically, significantly reduced delta rhythm along with reducing burst suppression and increasing BIS at 25 nmol kg(-1) during isoflurane anaesthesia. DSIP also significantly altered bilateral symmetry of EEG.
    CONCLUSION:
    DSIP probably reduced parasympathetic tone and decreased (lightened) the depth of anaesthesia measured using BIS.

    Related product list:
    T-A001 MGF 2mg/vial
    T-A002 PEG MGF 2mg/vial
    T-A003 CJC-1295 with DAC 2mg//vial
    T-A004 CJC-1295 without DAC 2mg//vial
    T-A005 PT-141 10mg//vial
    T-A006 MT-1 10mg//vial
    T-A007 MT-2 10mg//vial
    T-A008 GHRP-2 5mg//vial
    T-A008 GHRP-2 10mg//vial
    T-A009 GHRP-6 5mg//vial
    T-A009 GHRP-6 10mg//vial
    T-A010 Ipamorelin 2mg//vial
    T-A011 Hexarelin 2mg//vial
    T-A012 Sermorelin 2mg//vial
    T-A013 Oxytocin 1g, 2mg//vial
    T-A014 TB500 2mg//vial
    T-A015 pentadecapeptide BPC 157 2mg//vial
    T-A016 HGH 176-191 2mg//vial
    T-A017 Triptorelin 2mg//vial
    T-A018 Tesamorelin 2mg//vial
    T-A020 Gonadorelin 2mg//vial
    T-A020 Gonadorelin 10mg//vial
    T-A021 DSIP 2mg//vial
    T-A022 Selank 5mg//vial
  • DSIP (Delta sleep-inducing peptide)
  • DSIP (Delta sleep-inducing peptide)